Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The Communication of Multiple Sclerosis Diagnosis: The Patients' Perspective.
Validation of mood measures for people with multiple sclerosis.
Online health information seeking: how people with multiple sclerosis find, assess and integrate treatment information to manage their health.
Acute-Phase Protein Hemopexin Is a Negative Regulator of Th17 Response and Experimental Autoimmune Encephalomyelitis Development.
Factors Influencing Decision-making and Outcome in the Surgical Management of Trigeminal Neuralgia.
Repeatability of quantitative sodium magnetic resonance imaging for estimating pseudo-intracellular sodium concentration and pseudo-extracellular volume fraction in brain at 3 T.
Will CSF biomarkers guide future therapeutic decisions in multiple sclerosis?
Central nervous system de- and remyelination is independent from systemic cholesterol level in Theiler's murine encephalomyelitis.
A prospective study of patients with brain MRI showing incidental t2 hyperintensities addressed as multiple sclerosis: a lot of work to do before treating.
Immunoadsorption in steroid-refractory multiple sclerosis.
Cost analysis of glatiramer acetate vs. fingolimod for the treatment of patients with relapsing-remitting multiple sclerosis in Spain.
Role of hemoglobin/heme scavenger protein hemopexin in atherosclerosis and inflammatory diseases.
Anxiety and Depressive Symptoms Are Associated With Worse Performance on Objective Cognitive Tests in MS.
IL7Rα Expression and Upregulation by IFNβ in Dendritic Cell Subsets Is Haplotype-Dependent.
Aquaporin-4 antibody testing: direct comparison of M1-AQP4-DNA-transfected cells with leaky scanning versus M23-AQP4-DNA-transfected cells as antigenic substrate.
Correction: Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study.
Association of seasonal serum 25-hydroxyvitamin D levels with disability and relapses in relapsing-remitting multiple sclerosis.
IMMUNE SYSTEM INDUCTION OF NERVE GROWTH FACTOR IN AN ANIMAL MODEL OF MULTIPLE SCLEROSIS: IMPLICATIONS IN RE-MYELINATION AND MYELIN REPAIR.
Isoniazid in autoimmunity: a trigger for multiple sclerosis?
Highlights From the 2014 Joint Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)-European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).
Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells.
Wallerian and trans-synaptic degeneration contribute to optic radiation damage in multiple sclerosis: a diffusion tensor MRI study.
Secondary B Cell Receptor Diversification Is Necessary for T Cell Mediated Neuro-Inflammation during Experimental Autoimmune Encephalomyelitis.
Brain reserve and cognitive reserve in multiple sclerosis: What you've got and how you use it.
Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists.

Pages